These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 27743009)

  • 21. Opportunities for use of human iPS cells in predictive toxicology.
    Anson BD; Kolaja KL; Kamp TJ
    Clin Pharmacol Ther; 2011 May; 89(5):754-8. PubMed ID: 21430658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induced pluripotent stem cell-derived hepatocytes as an alternative to human adult hepatocytes.
    Katsuda T; Sakai Y; Ochiya T
    J Stem Cells; 2012; 7(1):1-17. PubMed ID: 23550341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells.
    Song Z; Cai J; Liu Y; Zhao D; Yong J; Duo S; Song X; Guo Y; Zhao Y; Qin H; Yin X; Wu C; Che J; Lu S; Ding M; Deng H
    Cell Res; 2009 Nov; 19(11):1233-42. PubMed ID: 19736565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of pig induced pluripotent stem cells with a drug-inducible system.
    Wu Z; Chen J; Ren J; Bao L; Liao J; Cui C; Rao L; Li H; Gu Y; Dai H; Zhu H; Teng X; Cheng L; Xiao L
    J Mol Cell Biol; 2009 Oct; 1(1):46-54. PubMed ID: 19502222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of induced pluripotent stem cells from virus-free in vivo reprogramming of BALB/c mouse liver cells.
    de Lázaro I; Bussy C; Yilmazer A; Jackson MS; Humphreys NE; Kostarelos K
    Biomaterials; 2014 Sep; 35(29):8312-20. PubMed ID: 25002261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
    Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
    Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct and indirect contribution of human embryonic stem cell-derived hepatocyte-like cells to liver repair in mice.
    Woo DH; Kim SK; Lim HJ; Heo J; Park HS; Kang GY; Kim SE; You HJ; Hoeppner DJ; Kim Y; Kwon H; Choi TH; Lee JH; Hong SH; Song KW; Ahn EK; Chenoweth JG; Tesar PJ; McKay RD; Kim JH
    Gastroenterology; 2012 Mar; 142(3):602-11. PubMed ID: 22138358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A stable chimeric fibroblast growth factor (FGF) can successfully replace basic FGF in human pluripotent stem cell culture.
    Onuma Y; Higuchi K; Aiki Y; Shu Y; Asada M; Asashima M; Suzuki M; Imamura T; Ito Y
    PLoS One; 2015; 10(4):e0118931. PubMed ID: 25850016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lectin from Erythrina cristagalli supports undifferentiated growth and differentiation of human pluripotent stem cells.
    Mikkola M; Toivonen S; Tamminen K; Alfthan K; Tuuri T; Satomaa T; Natunen J; Saarinen J; Tiittanen M; Lampinen M; Valmu L; Partanen J; Otonkoski T
    Stem Cells Dev; 2013 Mar; 22(5):707-16. PubMed ID: 23106381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are we there yet? Navigating roadblocks to induced pluripotent stem cell therapy translation.
    Parker SL; Perlingeiro RC
    Regen Med; 2013 Jul; 8(4):389-91. PubMed ID: 23826691
    [No Abstract]   [Full Text] [Related]  

  • 31. Molecular analysis of FMR1 reactivation in fragile-X induced pluripotent stem cells and their neuronal derivatives.
    Bar-Nur O; Caspi I; Benvenisty N
    J Mol Cell Biol; 2012 Jun; 4(3):180-3. PubMed ID: 22430918
    [No Abstract]   [Full Text] [Related]  

  • 32. Reprogram or reboot: small molecule approaches for the production of induced pluripotent stem cells and direct cell reprogramming.
    Jung DW; Kim WH; Williams DR
    ACS Chem Biol; 2014 Jan; 9(1):80-95. PubMed ID: 24245936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitochondrial development of the in vitro hepatic organogenesis model with simultaneous cardiac mesoderm differentiation from murine induced pluripotent stem cells.
    Tamai M; Yamashita A; Tagawa Y
    J Biosci Bioeng; 2011 Nov; 112(5):495-500. PubMed ID: 21816670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation of 5-HT4 receptor enhances differentiation of mouse induced pluripotent stem cells into neural progenitor cells.
    Ishizuka T; Goshima H; Ozawa A; Watanabe Y
    Clin Exp Pharmacol Physiol; 2014 May; 41(5):345-50. PubMed ID: 24606396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Keratinocyte growth factor and dexamethasone plus elevated cAMP levels synergistically support pluripotent stem cell differentiation into alveolar epithelial type II cells.
    Schmeckebier S; Mauritz C; Katsirntaki K; Sgodda M; Puppe V; Duerr J; Schubert SC; Schmiedl A; Lin Q; Paleček J; Draeger G; Ochs M; Zenke M; Cantz T; Mall MA; Martin U
    Tissue Eng Part A; 2013 Apr; 19(7-8):938-51. PubMed ID: 23176317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoting effect of 1,25(OH)2 vitamin D3 in osteogenic differentiation from induced pluripotent stem cells to osteocyte-like cells.
    Kato H; Ochiai-Shino H; Onodera S; Saito A; Shibahara T; Azuma T
    Open Biol; 2015 Feb; 5(2):140201. PubMed ID: 25652541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Highlight report: perspectives in stem cell research--unbiased quantification of the similarity between in vitro generated and primary hepatocytes.
    Ghallab A
    Arch Toxicol; 2015 Nov; 89(11):2185-7. PubMed ID: 26410582
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro three-dimensional coculturing poly3-hydroxybutyrate-co-3-hydroxyhexanoate with mouse-induced pluripotent stem cells for myocardial patch application.
    Shijun X; Junsheng M; Jianqun Z; Ping B
    J Biomater Appl; 2016 Mar; 30(8):1273-82. PubMed ID: 26873635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analysis of human embryonic stem cell and induced pluripotent stem cell-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation.
    Jozefczuk J; Prigione A; Chavez L; Adjaye J
    Stem Cells Dev; 2011 Jul; 20(7):1259-75. PubMed ID: 21162674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induced pluripotent stem cells: opportunities as research and development tools in 21st century drug discovery.
    Rowntree RK; McNeish JD
    Regen Med; 2010 Jul; 5(4):557-68. PubMed ID: 20632859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.